全文获取类型
收费全文 | 3169篇 |
免费 | 396篇 |
国内免费 | 30篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 171篇 |
妇产科学 | 102篇 |
基础医学 | 333篇 |
口腔科学 | 71篇 |
临床医学 | 314篇 |
内科学 | 994篇 |
皮肤病学 | 40篇 |
神经病学 | 102篇 |
特种医学 | 551篇 |
外科学 | 269篇 |
综合类 | 37篇 |
预防医学 | 225篇 |
眼科学 | 35篇 |
药学 | 134篇 |
1篇 | |
中国医学 | 1篇 |
肿瘤学 | 209篇 |
出版年
2022年 | 17篇 |
2021年 | 34篇 |
2020年 | 20篇 |
2019年 | 36篇 |
2018年 | 47篇 |
2017年 | 32篇 |
2016年 | 45篇 |
2015年 | 50篇 |
2014年 | 63篇 |
2013年 | 93篇 |
2012年 | 80篇 |
2011年 | 98篇 |
2010年 | 91篇 |
2009年 | 119篇 |
2008年 | 87篇 |
2007年 | 107篇 |
2006年 | 104篇 |
2005年 | 93篇 |
2004年 | 88篇 |
2003年 | 94篇 |
2002年 | 79篇 |
2001年 | 89篇 |
2000年 | 103篇 |
1999年 | 102篇 |
1998年 | 135篇 |
1997年 | 154篇 |
1996年 | 134篇 |
1995年 | 90篇 |
1994年 | 106篇 |
1993年 | 115篇 |
1992年 | 74篇 |
1991年 | 68篇 |
1990年 | 59篇 |
1989年 | 75篇 |
1988年 | 71篇 |
1987年 | 59篇 |
1986年 | 73篇 |
1985年 | 65篇 |
1984年 | 54篇 |
1983年 | 39篇 |
1982年 | 31篇 |
1981年 | 49篇 |
1980年 | 33篇 |
1979年 | 30篇 |
1978年 | 25篇 |
1977年 | 40篇 |
1976年 | 55篇 |
1975年 | 26篇 |
1974年 | 18篇 |
1973年 | 22篇 |
排序方式: 共有3595条查询结果,搜索用时 10 毫秒
31.
32.
Permeation of human ovarian tissue with cryoprotective agents in preparation for cryopreservation 总被引:18,自引:10,他引:18
Newton H; Fisher J; Arnold JR; Pegg DE; Faddy MJ; Gosden RG 《Human reproduction (Oxford, England)》1998,13(2):376-380
The recent improvements in the treatment of cancer by chemo- and
radiotherapy have led to a significant increase in the survival rates of
patients with malignant disease, but at the expense of distressing side
effects. One major problem, especially for younger patients, is that
aggressive therapy destroys a significant proportion of the follicular
population, which can result in either temporary or permanent infertility.
Freeze-banking pieces of ovarian cortex prior to treatment is one strategy
for preserving fecundity. When the patient is in remission, fertility
could, theoretically, be restored by autografting the thawed tissue at the
orthotopic site or by growing isolated follicles to maturity in vitro.
Recent studies have found good follicular survival in frozen-thawed human
ovarian tissue but to optimize the process an effective cryopreservation
method needs to be developed. An essential part of such a technique is to
permeate the tissue with a cryoprotectant to minimize ice formation and the
extent of this equilibration is an important determinant of post-thaw
cellular survival. In the current study, we have investigated the diffusion
of four cryoprotective agents into human tissue at both 4 degrees C and 37
degrees C. We have also studied the effect of adding different
concentrations of the non penetrating cryoprotective agent, sucrose, to the
freezing media using the release of lactate dehydrogenase as a measure of
its protective effect. At 4 degrees C propylene glycol and glycerol
penetrated the tissue significantly slower than either ethylene glycol or
dimethyl sulphoxide. At the higher temperature of 37 degrees C all four
cryoprotectants penetrated at a faster rate, however concern about enhanced
toxicity prevents the use of these conditions in practice. Thus, the
results suggest that the best method of preparing tissue for freezing is
exposure for 30 min to 1.5 M solutions of ethylene glycol or dimethyl
sulphoxide at 4 degrees C; this achieved a mean tissue concentration that
was almost 80% that of the bathing solution. We also report that the
addition of low concentrations of sucrose to the freezing medium does not
have a significant protective effect against freezing injury.
相似文献
33.
Stein TP; Oram-Smith JC; Leskiw MJ; Wallace HW; Long LC; Leonard JM 《The American journal of physiology》1976,230(5):1321-1325
34.
35.
Vaughan JR; Farrer MJ; Wszolek ZK; Gasser T; Durr A; Agid Y; Bonifati V; DeMichele G; Volpe G; Lincoln S; Breteler M; Meco G; Brice A; Marsden CD; Hardy J; Wood NW 《Human molecular genetics》1998,7(4):751-753
A mutation in exon 4 of the human alpha-synuclein gene was reported
recently in four families with autosomal dominant Parkinson's disease (PD).
In order to examine whether mutations in this exon or elsewhere in the gene
are common in familial PD, all seven exons of the alpha- synuclein gene
were amplified by PCR from index cases of 30 European and American
Caucasian kindreds affected with autosomal dominant PD. Each product was
sequenced directly and examined for mutations in the open reading frame. No
mutations were found in any of the samples examined. We conclude that the
A53T change described in the alpha- synuclein gene is a rare cause of PD or
may even be a rare variant. Mutations in the regulatory or intronic regions
of the gene were not excluded by this study.
相似文献
36.
Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1 总被引:10,自引:0,他引:10
Lemmens I; Van de Ven WJ; Kas K; Zhang CX; Giraud S; Wautot V; Buisson N; De Witte K; Salandre J; Lenoir G; Pugeat M; Calender A; Parente F; Quincey D; Gaudray P; De Wit MJ; Lips CJ; Hoppener JW; Khodaei S; Grant AL; Weber G; Kytola S; Teh BT; Farnebo F; Thakker RV 《Human molecular genetics》1997,6(7):1177-1183
37.
Rigor and resistance to stretch in vertebrate smooth muscle 总被引:2,自引:0,他引:2
38.
Israel E Chervinsky PS Friedman B Van Bavel J Skalky CS Ghannam AF Bird SR Edelman JM 《The Journal of allergy and clinical immunology》2002,110(6):847-854
BACKGROUND: Maintaining asthma control is a major objective of therapy. Traditionally, the effectiveness of asthma therapy has been judged primarily by its effect on airway function rather than on multiaspect asthma control. OBJECTIVE: An inhaled corticosteroid and a leukotriene receptor antagonist were compared to determine whether they provided equivalent effects, as judged by days of asthma control. METHODS: In a randomized, multicenter, double-blind, placebo-controlled, parallel-group study, asthmatic patients (n = 782) with FEV(1) percent predicted values of between 50% and 85% and a weekly average beta-agonist use of more than 2 puffs per day were randomized to receive montelukast (10 mg daily), beclomethasone (200 microg twice daily), or placebo treatment for 6 weeks in a double-dummy fashion. We examined the distribution of the primary end point: percentage of days of asthma control. Secondary end points included FEV(1), albuterol use, occurrence of an asthma attack, asthma flare-up, rescue corticosteroid use, sustained asthma control, and adverse experiences. RESULTS: The percentage of days of asthma control was almost identical between the montelukast and beclomethasone groups (98% overlap in the distribution). Montelukast was at least equal to beclomethasone, and both were greater than placebo on the basis of frequency of asthma attacks, asthma flare-ups, and rescue corticosteroid use. Beclomethasone had a greater effect than montelukast and both treatments were better than placebo at improving FEV(1). CONCLUSIONS: Montelukast was as effective as beclomethasone, as judged by indices of clinical control other than FEV(1). When evaluating the outcome of montelukast therapy, FEV(1) might underestimate clinical effectiveness. 相似文献
39.
Billette J; Janse MJ; van Capelle FJ; Anderson RH; Touboul P; Durrer D 《The American journal of physiology》1976,231(4):1129-1139
40.